Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate

Details for Australian Patent Application No. 2003264968 (hide)

International Classifications

Event Publications

18 December 2003 Complete Application Filed

Priority application(s): 10-2002-0060798 05.10.02 KR; 10-2003-0053752 04.08.03 KR

27 May 2004 Application Open to Public Inspection

Published as AU-B-2003264968

16 March 2006 Application Accepted

Published as AU-B-2003264968

13 July 2006 Standard Patent Sealed

27 January 2011 Assignment Registered

Hanmi Pharm. Co., Ltd. The patent has been assigned to Hanmi Holdings Co., Ltd.

19 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.